← Open Payments lookup

CAROL MILLER: Open Payments

NPI 1306535927 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$525 in 16 payments from 7 companies in 2025. Trend: 2023 $502 · 2024 $588 · 2025 $525

Food & beverage: $525
CompanyPaymentsAmount
Janssen Biotech, Inc.7$189
GENZYME CORPORATION2$157
Takeda Pharmaceuticals U.S.A., Inc.3$75
Adaptive Biotechnologies Corporation1$32
BeOne Medicines USA, Inc.1$29
Celgene Corporation1$22
Legend Biotech USA Inc.1$21

Products named: SARCLISA, CARVYKTI, TECVAYLI, NINLARO, clonoSEQ, TALVEY, BRUKINSA, ABECMA.

Industry payments across TX — which companies pay providers there.